Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/11/2003US20030228360 Combination immediate release controlled release levodopa/carbidopa dosage forms
12/11/2003US20030228359 Antiallergen mixture
12/11/2003US20030228358 Mixture containing low solubility drug and polymer
12/11/2003US20030228357 Sizing, compaction, forming tablets
12/11/2003US20030228356 Surgically implanted time release medication for post-surgical treatment of a patient
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030228354 Drug in pressure sensitive adhesive
12/11/2003US20030228353 Wound heraling agents; polypeptide
12/11/2003US20030228350 Sustained release; drug delivery
12/11/2003US20030228345 Genetic engineered protein; bone disorders
12/11/2003US20030228335 Prevention, therapy of skin disorders; mixture of halogenated hydrocarbon and anhydrous lipid
12/11/2003US20030228299 Using superoxide dismutase
12/11/2003US20030228285 Bipartite T-cell factor (Tcf)-responsive promoter
12/11/2003US20030228273 Novel high viscosity embolizing compositions comprising prepolymers
12/11/2003US20030228260 Drug delivery; central nervous system disorders
12/11/2003CA2488269A1 Methods and compositions for intravesical therapy of bladder cancer
12/11/2003CA2488251A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same
12/11/2003CA2487882A1 Transmucosal delivery of cannabinoids
12/11/2003CA2487867A1 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
12/11/2003CA2487786A1 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
12/11/2003CA2487757A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
12/11/2003CA2487720A1 Therapeutic agent-containing polymeric nanoarticles
12/11/2003CA2487678A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/11/2003CA2487639A1 Self-administered contraceptive injection of oily solution
12/11/2003CA2487585A1 Formulations for amylin agonist peptides
12/11/2003CA2487577A1 Implantable polymeric device for sustained release of buprenorphine
12/11/2003CA2487305A1 Topical drug delivery using phosphatidylcholine
12/11/2003CA2486794A1 Pharmaceutical composition for controlled drug delivery system
12/11/2003CA2486424A1 Oil-soluble pigment compositions
12/11/2003CA2485932A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
12/11/2003CA2485533A1 Immediate release pharmaceutical formulation
12/11/2003CA2485080A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof
12/11/2003CA2484626A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/11/2003CA2483834A1 Norethindrone sustained release formulations and methods associated therewith
12/10/2003EP1369432A2 Soluble highly branched glucose polymers and process for their preparation
12/10/2003EP1369133A1 Gene carriers with the use of polysaccharide and process for producing the same
12/10/2003EP1369132A1 Oxaliplatin containing liposome preparation
12/10/2003EP1369131A1 Utilization of spray-dried powder containing sugar alcohol
12/10/2003EP1369130A1 Process for producing sustained release preparation
12/10/2003EP1369123A1 A health-care product comprising lotus rhizome and process for its preparation
12/10/2003EP1369122A1 Anticancer agent
12/10/2003EP1369115A1 Methods of preventing breast cancer by the administration of Raloxifene
12/10/2003EP1369113A1 Solubilisation of drugs in HFA propellant by means of emulsions
12/10/2003EP1369112A1 Percutaneous absorption-type pharmaceutical preparation and process for producing the same
12/10/2003EP1369111A1 Hydrophilic microparticles and methods to prepare same
12/10/2003EP1369110A1 Production of nanoparticles from methyl vinyl ether copolymer and maleic anhydride for the administration of hydrophilic pharmaceuticals, more particularly of puric and pyrimidinic bases
12/10/2003EP1369109A1 Preparations quickly disintegrating in oral cavity
12/10/2003EP1369108A1 Composition for use in electroporation
12/10/2003EP1368486A2 Formulations for il-11
12/10/2003EP1368419A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
12/10/2003EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic
12/10/2003EP1368322A2 New crystal forms of oxcarbazepine and processes for their preparation
12/10/2003EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
12/10/2003EP1368182A1 A tablet press machine
12/10/2003EP1368090A1 Apparatus for dispensing powdered material
12/10/2003EP1368079A1 Non-constant pressure infusion pump
12/10/2003EP1368063A2 Complex of modafinil and cyclodextrin
12/10/2003EP1368062A2 Composition and method
12/10/2003EP1368057A2 Method to enhance the immunogenicity of an antigen
12/10/2003EP1368048A1 Pharmaceutical composition made of cannabis extracts
12/10/2003EP1368047A1 Composition containing asiasari radix extracts for protecting brain cells and improving memory
12/10/2003EP1368045A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins
12/10/2003EP1368041A1 Amphotericin b aqueous composition
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368033A2 Method and apparatus for treating breakthrough pain
12/10/2003EP1368023A1 Utilization of buprenorphine in urinary incontinence therapy
12/10/2003EP1368019A1 Esmolol formulation
12/10/2003EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
12/10/2003EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1368005A2 Chronotherapeutic dosage forms
12/10/2003EP1368004A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/10/2003EP1368003A1 Methods and compositions for reducing the taste of pharmaceutically active agents
12/10/2003EP1368002A2 Method for producing a floating tablet containing alfuzosine
12/10/2003EP1368001A2 Pharmaceutical formulation comprising bicalutamide
12/10/2003EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367997A1 Injectable water-in-oil emulsions
12/10/2003EP1367996A1 Sustained-release suspension of ceftiofur hydrochloride
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367994A2 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
12/10/2003EP1367981A2 Pearlescent agent
12/10/2003EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/10/2003EP1367970A1 Alkyl aryl polyether alcohol polymers for improvement of nasal breathing
12/10/2003EP1289364B1 Stable gabapentin containing more than 2o ppm of chlorine ion
12/10/2003EP1276466B1 Directly compressed solid dosage particles
12/10/2003EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules
12/10/2003EP1124582B1 Preservative system for topically administrable pharmaceutical compositions
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP1021165B1 Bioerodable polymeric adhesives for tissue repair
12/10/2003EP1017365B1 Liposome-entrapped polynucleotide composition and method
12/10/2003EP0904060B1 Antifungal compositions with improved bioavailability
12/10/2003EP0883400B1 Delivery system for localized administration of medicaments to the upper respiratory tract
12/10/2003EP0781125B1 Enteric film coating compositions, method of coating therewith, and coated forms
12/10/2003EP0668757B1 Compositions of insoluble film-forming polymers and uses therefor
1 ... 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 ... 2991